UCB drugs company invests $20m and signs licensing agreement worth up to $725m with Synosia Therapeutics.

Pak Jerry, president of Indonesia-based Inovisi, says $30m investment and partnership with Ozura World will enable the company to ride on the mobile internet phenomenon.

Novartis and Truffle Capital part of consortium in $25.8m C round for Switzerland's Symetis.

Aspen Aerogels raises more than $110m in aggregate with latest series B round of funding led by Germany-based chemical conglomerate BASF.

UK-listed pharmaceutical company GlaxoSmithKline will own 18% of Convergence after asset spin-off.

Tobira Therapeutics raises $31m in its series B round.

Russian government venture capital fund, an international venture capital fund and two unnamed private strategic investors join $176m series D round investment consortium for BrightSource Energy.

Undisclosed strategic backs storage company Aster Data's C round.

Third Rock Ventures and Roche Venture Fund invest $30m in CytomX Therapeutics

NuvoSun raises $20m from Dow Chemicals in second tranche of the year.